Previously called NTHL1-associated polyposis, today, the preferred name for this syndrome is NTHL1 Tumor Syndrome, based on the high risk to different benign and malignant tumor types that biallelic variants in NTHL1 confer [59]. The gene discussed is NTHL1; the disease is cancer.